Free shipping on all orders over $ 500

RRX-001

Cat. No. M10583

All AbMole products are for research use only, cannot be used for human consumption.

RRX-001 Structure
Synonym:

Nibrozetone; ABDNAZ

Size Price Availability Quantity
5mg USD 140 In stock
10mg USD 190 In stock
25mg USD 380 In stock
50mg USD 620 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rrx-001 is a hypoxic selective epigenetic factor that has been used as a radiation or chemotherapy sensitizer to induce apoptosis. Rrx-001 is an immune checkpoint inhibitor that down-regulates CD47 and SIRP-α. Rrx-001 is also an effective inhibitor of G6PD with strong antimalarial activity. Rrx-001 inhibits the expression of CD47 in tumor cells by inhibiting c-myC, a positive regulator of CD47.


Chemical Information
Molecular Weight 268.02
Formula C5H6BrN3O5
CAS Number 925206-65-1
Form Solid
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bryan Oronsky, et al. Discov Med. RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells

[2] Bryan Oronsky, et al. Clin Epigenetics. RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors

[3] D Sharma Das, et al. Leukemia. A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells

[4] Shoucheng Ning, et al. Oncotarget. Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001

[5] Ozlem Yalcin, et al. Malar J. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria

Related NLR Products
Nodinitib-1

Nodinitib-1 (ML130) is a potent and selective inhibitor of NOD1 with IC50 of 0.56 μM, inhibits NF-κB activation, exhibits 36-fold selectivity over NOD2.

Ruscogenin

Ruscogenin is an important steroid saponin extracted from Ophiopogon japonicum. It alleviates blood-brain barrier dysfunction induced by cerebral ischemia by inhibiting TXNIP/NLRP3 inflammatory body activation and MAPK pathway, and has significant anti-inflammatory and antithrombotic activities.

Procyanidin-B2

Procyanidin B2 is a natural flavonoid with anti-tumor and anti-oxidation effects. Procyanidin B2 inhibited NLRP3 inflammasome activation via suppression of AP-1 pathway.

Oridonin

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Oridonin (NSC-250682) also acts as an inhibitor of AKT, with IC50 values of 8.4 and 8.9 μM for AKT1 and AKT2, respectively.

Shionone

Shionone, isolated from Aster Tataricus, is a triterpenoid compound with antitussive and anti-inflammatory activities. Shionone has a unique six-membered four-ring framework and a 3-oxygen-4-monomethyl structure.

  Catalog
Abmole Inhibitor Catalog




Keywords: RRX-001, Nibrozetone; ABDNAZ supplier, NLR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.